# Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

> **NCT03560362** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Tennessee** · enrollment: 50 (estimated)

## Conditions studied

- Pain, Postoperative
- Lung Cancer

## Interventions

- **DRUG:** Bupivacaine liposome
- **DRUG:** Bupivacaine / Epinephrine

## Key facts

- **NCT ID:** NCT03560362
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07-09
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560362, "Postoperative Pain Control With Lipossomic Extended Release Bupivacaine". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03560362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*